Bright Minds Biosciences Inc. (DRUG)

Bright Minds Biosciences Inc. (DRUG) is a healthcare company (biotechnology) based in the United States. The share price is $21.11, down 6.63% on the day, which values the company at $208.23M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$21.11−6.63% today
Market value
$208.23M
200-week average
$30.9132% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Bright Minds Biosciences Inc. in more detail

DRUG trades at -3.9× next year's expected earnings. It sits 32% below its 200-week average of $30.91.

In its favour: More cash than debt. Worth checking: Share count keeps rising.

1 of the superinvestors tracked here hold DRUG, including Peter Kolchinsky (0.2% of the portfolio).

Superinvestors holding DRUG

1 of the investors tracked here report a position in their latest 13F filing.

Bright Minds Biosciences Inc. (DRUG): questions and answers

What is Bright Minds Biosciences Inc.'s market cap?

Bright Minds Biosciences Inc. is valued at $208.23M at a share price of $21.11.

Is DRUG above its 200-week moving average?

No. DRUG is 31.7% below its 200-week average of $30.91. Long-term investors watch that line because strong companies rarely trade below it for long.

Does DRUG pay a dividend?

Bright Minds Biosciences Inc. does not currently pay a regular dividend.

Which famous investors own DRUG?

In their latest quarterly filings, Peter Kolchinsky (0.2% of the portfolio) hold DRUG. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

When does Bright Minds Biosciences Inc. report earnings next?

Bright Minds Biosciences Inc.'s next earnings report is expected on December 22, 2026. The date comes from the market data feed and companies do move it.

Cite this page

Funkfolio, “Bright Minds Biosciences Inc. (DRUG) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/DRUG

Underlying data: Yahoo Finance; company filings with the SEC.